These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 1621839)

  • 21. Antihypertensive effects of chicken extract against deoxycorticosterone acetate-salt-induced hypertension in rats.
    Matsumura Y; Okui T; Ono H; Kiso Y; Tanaka T
    Biol Pharm Bull; 2001 Oct; 24(10):1181-4. PubMed ID: 11642328
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endothelin-1-induced venous contraction is maintained in DOCA-salt hypertension; studies with receptor agonists.
    Watts SW; Fink GD; Northcott CA; Galligan JJ
    Br J Pharmacol; 2002 Sep; 137(1):69-79. PubMed ID: 12183332
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diverse effects of renal denervation on ventricular hypertrophy and blood pressure in DOCA-salt hypertensive rats.
    Cabral AM; Silva IF; Gardioli CR; Mauad H; Vasquez EC
    Braz J Med Biol Res; 1998 Apr; 31(4):587-90. PubMed ID: 9698814
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Retardation of the development of hypertension in DOCA-salt rats by renal denervation.
    Takahashi H; Iyoda I; Yamasaki H; Takeda K; Okajima H; Sasaki S; Yoshimura M; Nakagawa M; Ijichi H
    Jpn Circ J; 1984 Jun; 48(6):567-74. PubMed ID: 6547490
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PI3-kinase upregulation and involvement in spontaneous tone in arteries from DOCA-salt rats: is p110delta the culprit?
    Northcott CA; Hayflick JS; Watts SW
    Hypertension; 2004 Apr; 43(4):885-90. PubMed ID: 14993194
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of angiotensin II in cerebrovascular and renal damage in deoxycorticosterone acetate-salt hypertensive rats.
    Wada T; Kanagawa R; Ishimura Y; Inada Y; Nishikawa K
    J Hypertens; 1995 Jan; 13(1):113-22. PubMed ID: 7759841
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diosmin, a bioflavonoid reverses alterations in blood pressure, nitric oxide, lipid peroxides and antioxidant status in DOCA-salt induced hypertensive rats.
    Silambarasan T; Raja B
    Eur J Pharmacol; 2012 Mar; 679(1-3):81-9. PubMed ID: 22266490
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of manidipine on cardiac hypertrophy and coronary circulation in DOCA/salt hypertensive rats.
    Takeda K; Nakata T; Kuwabara T; Itoh H; Yamahara Y; Takesako T; Tanabe S; Sasaki S; Asayama J; Nakagawa M
    Blood Press Suppl; 1992; 3():48-52. PubMed ID: 1343289
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Morphological and biochemical characterization of remodeling in aorta and vena cava of DOCA-salt hypertensive rats.
    Watts SW; Rondelli C; Thakali K; Li X; Uhal B; Pervaiz MH; Watson RE; Fink GD
    Am J Physiol Heart Circ Physiol; 2007 May; 292(5):H2438-48. PubMed ID: 17237246
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chlorthalidone-modulated vascular responses to vasodilator stimuli in DOCA-salt hypertensive rats.
    Bissoli NS; Vasquez EC; Cabral AM
    Pharmacol Res; 1996 Jan; 33(1):47-54. PubMed ID: 8817646
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of indapamide on the mechanical properties of the arterial wall in deoxycorticosterone acetate-salt hypertensive rats.
    Levy BI; Poitevin P; Safar ME
    Am J Cardiol; 1990 May; 65(17):28H-32H. PubMed ID: 2330906
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impairment of neurally-mediated vasoconstriction in DOCA-salt hypertensive dogs.
    Hamed AT; Lokhandwala MF
    Clin Exp Hypertens A; 1982; 4(6):867-81. PubMed ID: 6284412
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Estrogen metabolite 2-methoxyestradiol prevents hypertension in deoxycorticosterone acetate-salt rats.
    Yuan W; Yu Y; Li J; Singh P; Li D; Gui Y; Zheng XL
    Cardiovasc Drugs Ther; 2013 Feb; 27(1):17-22. PubMed ID: 23229845
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Body fluid distribution in the maintenance of DOCA-salt hypertension in rats.
    Tajima Y; Ichikawa S; Sakamaki T; Matsuo H; Aizawa F; Kogure M; Yagi S; Murata K
    Am J Physiol; 1983 May; 244(5):H695-700. PubMed ID: 6846557
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reversal of cardiac fibrosis in deoxycorticosterone acetate-salt hypertensive rats by inhibition of the renin-angiotensin system.
    Brown L; Duce B; Miric G; Sernia C
    J Am Soc Nephrol; 1999 Jan; 10 Suppl 11():S143-8. PubMed ID: 9892155
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Central action of increased osmolality to support blood pressure in deoxycorticosterone acetate-salt rats.
    O'Donaughy TL; Qi Y; Brooks VL
    Hypertension; 2006 Oct; 48(4):658-63. PubMed ID: 16966581
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Renal AT1 receptor: computerized quantification in spontaneously hypertensive rats and DOCA-salt rats.
    Asano N; Ogura T; Mimura Y; Otsuka F; Kishida M; Hashimoto M; Yamauchi T; Makino H
    Res Commun Mol Pathol Pharmacol; 1998 May; 100(2):171-80. PubMed ID: 9667071
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiac hypertrophy developing during DOCA-salt treatment is dissociated from systemic and regional hemodynamics.
    Kobrin I; Eimerl J; Mekler J; Ben-Ishay D
    Am J Hypertens; 1990 Feb; 3(2):136-9. PubMed ID: 2137702
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Changes in blood pressure and extracellular fluid with taurine in DOCA-salt rats.
    Fujita T; Sato Y
    Am J Physiol; 1986 Jun; 250(6 Pt 2):R1014-20. PubMed ID: 3717374
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardiac sympathetic hyperinnervation in deoxycorticosterone acetate-salt hypertensive rats.
    Lee TM; Chen CC; Chang NC
    Clin Sci (Lond); 2012 Oct; 123(7):445-57. PubMed ID: 22507072
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.